Literature DB >> 1478037

A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test.

P Galvin1, G Ward, J Walters, R Pestell, M Koschmann, A Vaag, I Martin, J D Best, F Alford.   

Abstract

Both insulin secretion and insulin sensitivity are important in the development of diabetes but current methods used for their measurements are complex and cannot be used for epidemiological surveys. This study describes a simplified approach for the estimation of first phase insulin release and insulin sensitivity from a standard 40-min intravenous glucose tolerance test (IVGTT), and compares these parameter estimations with the sophisticated minimal model analysis of a frequently sampled 3-h IVGTT and the euglycaemic clamp technique. For the simplified IVGTT, first phase insulin release was measured as the insulin area above basal post glucose load unit-1 incremental change (i.e. peak rise) in plasma glucose over 0-10 min, and insulin sensitivity as a rate of glucose disappearance (Kg) unit-1 insulin increase above basal from 0-40 min post-glucose load in 18 subjects who were studied twice, either basally or in a perturbed pathophysiological state (i.e. pre- and post-ultramarathon race, n = 5; pre- and post-20 h pulsatile hyperinsulinaemia, n = 8; pre- and post-thyrotoxic state, n = 5). A further 12 subjects were compared by IVGTT, and glucose clamp. In addition, seven dogs were studied three times by IVGTT during normal saline infusion and after short-term (1/2 hour) or long-term (72 hour) adrenaline infusions. First phase insulin release and insulin sensitivity estimated from the simplified IVGTT as calculated by the two methods correlated closely (rs = 0.89 and rs = 0.87, respectively), although less precisely in markedly insulin-resistant subjects and the slopes and y intercepts of the linear regression lines were similar in the basal and perturbed states.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478037     DOI: 10.1111/j.1464-5491.1992.tb01732.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  20 in total

1.  Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes.

Authors:  J Pihlajamäki; U Salmenniemi; M Vänttinen; E Ruotsalainen; J Kuusisto; I Vauhkonen; S Kainulainen; M C Y Ng; N J Cox; G I Bell; M Laakso
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

2.  Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population.

Authors:  Minrui Li; Shenghong Zhang; Yanqin Wu; Junzhao Ye; Xu Cao; Jie Liu; Yanhong Sun; Bihui Zhong
Journal:  Dig Dis Sci       Date:  2015-02-17       Impact factor: 3.199

3.  Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Authors:  Thomas F Lotz; J Geoffrey Chase; Kirsten A McAuley; Geoffrey M Shaw; Paul D Docherty; Juliet E Berkeley; Sheila M Williams; Christopher E Hann; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

4.  Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.

Authors:  J Wang; J Kuusisto; M Vänttinen; T Kuulasmaa; J Lindström; J Tuomilehto; M Uusitupa; M Laakso
Journal:  Diabetologia       Date:  2007-04-17       Impact factor: 10.122

Review 5.  Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods?

Authors:  L C Groop; E Widén; E Ferrannini
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

6.  Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial.

Authors:  Deborah M Mitchell; Benjamin Z Leder; Enrico Cagliero; Natalia Mendoza; Maria P Henao; Douglas L Hayden; Joel S Finkelstein; Sherri-Ann M Burnett-Bowie
Journal:  Am J Clin Nutr       Date:  2015-07-08       Impact factor: 7.045

7.  DISTq: An Iterative Analysis of Glucose Data for Low-Cost, Real-Time and Accurate Estimation of Insulin Sensitivity.

Authors:  Paul D Docherty; J Geoffrey Chase; Thomas Lotz; Christopher E Hann; Geoffrey M Shaw; Juliet E Berkeley; J I Mann; Kirsten McAuley
Journal:  Open Med Inform J       Date:  2009-12-02

8.  An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics.

Authors:  A Tura; S Sbrignadello; E Succurro; L Groop; G Sesti; G Pacini
Journal:  Diabetologia       Date:  2009-10-30       Impact factor: 10.122

9.  The effect of birthweight upon insulin resistance and associated cardiovascular risk factors in adolescence is not explained by fetal growth velocity in the third trimester as measured by repeated ultrasound fetometry.

Authors:  S E Vielwerth; R B Jensen; T Larsen; K K Holst; C Mølgaard; G Greisen; A Vaag
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

Review 10.  Severe insulin resistance syndromes.

Authors:  Angeliki M Angelidi; Andreas Filippaios; Christos S Mantzoros
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.